Creative Planning’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Creative Planning’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-62	Closed	–	–	4407
2017 Q2	$0	Hold	62	–	–	﹤0.01%	5002
2017 Q1	$0	Hold	62	–	–	﹤0.01%	5059
2016 Q4	$0	Hold	62	–	–	﹤0.01%	5002
2016 Q3	$0	Hold	62	–	–	﹤0.01%	4838
2016 Q2	$0	Hold	62	–	–	﹤0.01%	4629
2016 Q1	$0	Hold	62	–	–	﹤0.01%	4680
2015 Q4	$1K	Buy	+62	New	+$719	﹤0.01%	4317
2015 Q1	–	Sell	-1	Closed	–	–	4514
2014 Q4	$0	Hold	1	–	–	﹤0.01%	4452
2014 Q3	$0	Sell	1 -1,125	-100%	-$6.86K	﹤0.01%	4248
2014 Q2	$8K	Buy	1,126 +1,125	+112,500%	+$7.53K	﹤0.01%	3013
2014 Q1	$0	Buy	+1	New	+$7	﹤0.01%	3841
2013 Q4	–	Sell	-4	Closed	–	–	3557
2013 Q3	$0	Buy	+4	New	+$27	﹤0.01%	3433

Other funds holding JNP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

MERSOM

Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return

Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Creative Planning's JNP Position: Q3 2017 in Review

Creative Planning sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2017, closing a stake of 62 shares.

Creative Planning first reported a position in JNP in Q3 2013 and held it in 12 quarters. The position peaked at $8K in Q2 2014. 31 funds tracked by Wall St. Rank hold JNP as of Q3 2017.

Creative Planning reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
Creative Planning sold 62 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2017.
Creative Planning first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2013 and held it in 12 quarters.
Creative Planning's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $8K in Q2 2014.
31 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.